Real-world investigation of the use of a mental health chatbot app while waiting for mental health services

Not Applicable

Completed

• Conditions: Mental health; Mental and Behavioural Disorders

• Registration Number: ISRCTN14644939
• Lead Sponsor: niversity of Plymouth

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-01-17
• Study Completion: 2023-07-20
• Last Update Posted: 4 December 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 76

Inclusion Criteria

1. Willing and able to provide informed consent
2. Aged 18 years or older
3. User is confident in their ability to speak and understand English at a proficient level
4. Own a mobile device capable of supporting Wysa
5. A valid email address
6. Referred or self-referred to proceed through the standard IAPT care pathway

Exclusion Criteria

1. Patients ineligible for the standard IAPT care pathway
2. Patients with previous and current known major mental illness such as Schizophrenia, severe depression, any co-morbid neurological or neuro-psychiatric condition such as epilepsy
3. Patients with current psychosis or a history of psychotic symptoms within the last 6 months
4. Patients with suicidal ideation
5. Patients scoring > 15 points on PHQ 9
6. Patients scoring > GAD-7
7. Patients with significant cognitive disorders
8. Patients with noted neurodevelopmental conditions such as autism or ADHD
9. Patients previously diagnosed with a personality disorder
10. Patients who been under the care of CMHT or a specialised mental health services in the last 2 years
11. Patients who failed IAPT previously
12. Patients with referrals for specialist presentations of pre-existing, diagnosed conditions requiring a specialised assessment beyond the standard clinical pathway
13. Incapable of self-consent
14. In a dependent/unequal relationship with the research or care teams or any PPI representatives

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Depression severity measured using the Patient Health Questionnaire-9 (PHQ-9) at baseline and 3 months